| Literature DB >> 35267918 |
Mami Takimoto1, Sonoko Yasui-Yamada1, Nanami Nasu1, Natsumi Kagiya1, Nozomi Aotani1, Yumiko Kurokawa1, Yoshiko Tani-Suzuki1, Hideya Kashihara2, Yu Saito1,2, Masaaki Nishi2, Mitsuo Shimada2, Yasuhiro Hamada1.
Abstract
The Global Leadership Initiative on Malnutrition (GLIM) criteria recommends using race- and sex-adjusted cutoff values for reduced muscle mass (RMM), but the only cutoff values available for Asians are the skeletal muscle mass index (SMI) established by the Asian Working Group for Sarcopenia (AWGS). This retrospective study aimed to develop and validate cutoff values for the fat-free mass index (FFMI) and arm circumference (AC) of Asians, and to investigate the association between GLIM malnutrition and prognosis. A total of 660 patients with primary gastrointestinal (GI) and hepatobiliary-pancreatic (HBP) cancers who underwent their first resection surgery were recruited and randomly divided into development and validation groups. The FFMI and AC cutoff values were calculated by receiver operating characteristic curve analysis for the AWGS SMI as the gold standard. The cutoff values for each RMM were used to diagnose malnutrition on the basis of GLIM criteria, and the survival rates were compared. The optimal FFMI cutoff values for RMM were 17 kg/m2 for men and 15 kg/m2 for women, and for AC were 27 cm for men and 25 cm for women. In the validation group, the accuracy of the FFMI and AC cutoff values to discriminate RMM were 85.2% and 68.8%, respectively. Using any of the three measures of RMM, overall survival rates were significantly lower in the GLIM malnutrition group. In conclusion, the cutoff values for the FFMI and AC in this study could discriminate RMM, and GLIM malnutrition using these cutoff values was associated with decreased survival.Entities:
Keywords: Global Leadership Initiative on Malnutrition; arm circumference; cutoff value; fat-free mass index; gastrointestinal cancer; reduced muscle mass
Mesh:
Year: 2022 PMID: 35267918 PMCID: PMC8912591 DOI: 10.3390/nu14050943
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Patient characteristics.
| All | Development | Validation | ||
|---|---|---|---|---|
| Age (years) | 70 (63–76) | 70 (64–76) | 70 (63–76) | 0.572 |
| Sex ( | 0.936 | |||
| Men | 407 (61.7) | 204 (61.8) | 203 (61.5) | |
| Women | 253 (38.3) | 126 (38.2) | 127 (38.5) | |
| Cancer site ( | 0.686 | |||
| Colorectal | 259 (39.2) | 137 (41.5) | 122 (37.0) | |
| Stomach | 188 (28.5) | 86 (26.1) | 102 (30.9) | |
| Liver | 81 (12.3) | 41 (12.4) | 40 (12.1) | |
| Bile duct | 59 (8.9) | 30 (9.1) | 29 (8.8) | |
| Pancreas | 73 (11.1) | 36 (10.9) | 37 (11.2) | |
| Stage ( | 0.169 | |||
| I | 206 (31.2) | 106 (32.1) | 100 (30.3) | |
| II | 236 (35.8) | 116 (35.2) | 120 (36.4) | |
| III | 156 (23.6) | 70 (21.2) | 86 (26.1) | |
| IV | 62 (9.4) | 38 (11.5) | 24 (7.3) | |
| Surgical approach ( | 0.876 | |||
| Laparotomy | 296 (44.9) | 147 (44.6) | 149 (45.2) | |
| Laparoscopic surgery | 364 (55.2) | 183 (55.5) | 181 (54.9) | |
| Preoperative therapy | 73 (11.1) | 35 (10.6) | 38 (11.5) | 0.710 |
| Adjuvant chemotherapy ( | 249 (37.7) | 127 (38.5) | 122 (37.0) | 0.688 |
| Height (cm) | 160.0 (152.0–167.0) | 160.0 (152.0–167.1) | 160.0 (151.8–167.0) | 0.649 |
| Body weight (kg) | 56.8 (49.0–64.4) | 57.2 (49.7–65.6) | 56.3 (48.7–63.7) | 0.305 |
| BMI (kg/m2) | 22.3 (20.3–24.2) | 22.4 (20.5–24.4) | 22.2 (20.1–24.0) | 0.289 |
| SMI (kg/m2) | 6.6 (5.7–7.4) | 6.7 (5.7–7.3) | 6.5 (5.7–7.4) | 0.595 |
| Low SMI * ( | 312 (47.3) | 155 (47.0) | 157 (47.6) | 0.876 |
| FFMI (kg/m2) | 16.4 (15.1–17.9) | 16.6 (15.1–17.9) | 16.3 (15.2–18.0) | 0.712 |
| AC (cm) | 26.6 (24.6–28.6) | 26.6 (24.6–28.6) | 26.7 (24.8–28.4) | 0.999 |
* Low SMI was defined as an SMI < 7.0 kg/m2 in men and SMI < 5.7 kg/m2 in women according to the cutoff value for AWGS. BMI, body mass index; SMI, skeletal muscle mass index; FFMI, fat-free mass index; AC, arm circumference; AWGS, Asian Working Group for Sarcopenia.
Figure 1ROC curves to determine the cutoff values for the FFMI and AC, which discriminate the cutoff value for the SMI according to AWGS in the development group. (A) FFMI in men; (B) FFMI in women; (C) AC in men; (D) AC in women. ROC, receiver operating characteristics; FFMI, fat-free mass index; AC, arm circumference; SMI, skeletal muscle mass index; AWGS, Asian Working Group for Sarcopenia; AUC, area under the curve.
Statistical evaluations of developed cutoff values for the FFMI and AC to discriminate the cutoff value for the SMI according to AWGS * in the validation group.
| FFMI ** | AC † | |
|---|---|---|
| Sensitivity (%) | 79.0 | 65.0 |
| Specificity (%) | 90.8 | 72.3 |
| PPV (%) | 88.6 | 68.0 |
| NPV (%) | 82.6 | 69.4 |
| Accuracy (%) | 85.2 | 68.8 |
* SMI < 7.0 kg/m2 in men, SMI < 5.7 kg/m2 in women. ** FFMI < 17 kg/m2 in men, <15 kg/m2 in women. † AC < 27 cm in men, <25 cm in women. FFMI, fat-free mass index; AC, arm circumference; SMI, skeletal muscle mass index; AWGS, Asian Working Group for Sarcopenia; PPV, positive predictive value; NPV, negative predictive value.
Statistical evaluations of GLIM malnutrition using FFMI or AC for GLIM malnutrition using the SMI * in the validation group.
| GLIM Using FFMI ** | GLIM Using AC † | |
|---|---|---|
| Sensitivity (%) | 93.2 | 91.9 |
| Specificity (%) | 100.0 | 99.2 |
| PPV (%) | 100.0 | 97.1 |
| NPV (%) | 98.1 | 97.7 |
| Accuracy (%) | 98.5 | 97.6 |
* SMI < 7.0 kg/m2 in men, SMI < 5.7 kg/m2 in women. ** FFMI < 17 kg/m2 in men, <15 kg/m2 in women. † AC < 27 cm in men, <25 cm in women. GLIM, Global Leadership Initiative on Malnutrition; FFMI, fat-free mass index; AC, arm circumference; SMI, skeletal muscle mass index; PPV, positive predictive value; NPV, negative predictive value.
Figure 2Kaplan–Meier survival curves by GLIM criteria malnutrition. (A) GLIM using SMI; (B) GLIM using FFMI; (C) GLIM using AC in all patients. GLIM, Global Leadership Initiative on Malnutrition; SMI, skeletal muscle mass index; FFMI, fat-free mass index; AC, arm circumference.